Impact of interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer patients

被引:0
作者
Shi-Wen Mei [1 ]
Zheng Liu [1 ]
Fang-Ze Wei [1 ]
Jia-Nan Chen [1 ]
Zhi-Jie Wang [1 ]
Hai-Yu Shen [1 ]
Juan Li [1 ]
Fu-Qiang Zhao [1 ]
Wei Pei [1 ]
Zheng Wang [1 ]
Xi-Shan Wang [1 ]
Qian Liu [1 ]
机构
[1] Department of Colorectal Surgery,National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College
关键词
D O I
暂无
中图分类号
R735.37 [];
学科分类号
100214 ;
摘要
BACKGROUND Epidemiologically, in China, locally advanced rectal cancer is a more common form of rectal cancer. Preoperative neoadjuvant concurrent chemoradiotherapy can effectively reduce the size of locally invasive tumors and improve disease-free survival(DFS) and pathologic response after surgery. At present, this modality has become the standard protocol for the treatment of locally advanced rectal cancer in many centers, but the optimal time for surgery after neoadjuvant therapy is still controversial.AIM To investigate the impact of time interval between neoadjuvant therapy and surgery on DFS and pathologic response in patients with locally advanced rectal cancer.METHODS A total of 231 patients who were classified as having clinical stage II or III advanced rectal cancer and underwent neoadjuvant chemoradiation followed by surgery at the National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College from November 2014 to August 2017 were involved in this retrospective cohort study. The patients were divided into two groups based on the different time intervals between neoadjuvant therapy and surgery: 139(60.2%) patients were in group A(≤ 9 wk), and 92(39.2%) patients were in group B(> 9 wk). DFS and pathologic response were analyzed as the primary endpoints. The secondary endpoints were postoperative complications and sphincter preservation.RESULTS For the 231 patients included, surgery was performed at ≤ 9 wk in 139(60.2%) patients and at > 9 wk in 92(39.8%). The patients’ clinical characteristics, surgical results, and tumor outcomes were analyzed through univariate analysis combined with multivariate regression analysis. The overall pathologic complete response(p CR) rate was 27.2%(n = 25) in the longer time interval group(> 9 wk) and 10.8%(n = 15) in the shorter time interval group(≤ 9 wk, P = 0.001). The postoperative complications did not differ between the groups(group A, 5% vs group B, 5.4%; P = 0.894). Surgical procedures for sphincter preservation were performed in 113(48.9%) patients, which were not significantly different between the groups(group A, 52.5% vs group B, 43.5%; P = 0.179). The p CR rate was an independent factor affected by time interval(P = 0.009; odds ratio [OR] = 2.668; 95%CI: 1.276-5.578). Kaplan-Meier analysis and Cox regression analysis showed that the longer time interval(> 9 wk) was a significant independent prognostic factor for DFS(P = 0.032; OR = 2.295; 95%CI: 1.074-4.905), but the time interval was not an independent prognostic factor for overall survival(P > 0.05).CONCLUSION A longer time interval to surgery after neoadjuvant therapy may improve the p CR rate and DFS but has little impact on postoperative complications and sphincter preservation.
引用
收藏
页码:4624 / 4638
页数:15
相关论文
共 15 条
  • [1] Neoadjuvant radiotherapy for rectal cancer management[J]. Gerard Feeney,Rishabh Sehgal,Margaret Sheehan,Aisling Hogan,Mark Regan,Myles Joyce,Michael Kerin.World Journal of Gastroenterology. 2019(33)
  • [2] Intraoperative intraperitoneal chemotherapy increases the incidence of anastomotic leakage after anterior resection of rectal tumors[J]. Zhi-Jie Wang,Jin-Hua Tao,Jia-Nan Chen,Shi-Wen Mei,Hai-Yu Shen,Fu-Qiang Zhao,Qian Liu.World Journal of Gastrointestinal Oncology. 2019(07)
  • [3] Sphincter-preserving R0 total mesorectal excision with resection of internal genitalia combined with pre-or postoperative chemoradiation for T4 rectal cancer in females
    Bartlomiej Szynglarewicz
    Rafal Matkowski
    Piotr Kasprzak
    Daniel Sydor
    Jozef Forgacz
    Marek Pudelko
    Jan Kornafel
    [J]. World Journal of Gastroenterology, 2007, (16) : 2339 - 2343
  • [4] Randomized clinical trial of short or long interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer
    Akgun, E.
    Caliskan, C.
    Bozbiyik, O.
    Yoldas, T.
    Sezak, M.
    Ozkok, S.
    Kose, T.
    Karabulut, B.
    Harman, M.
    Ozutemiz, O.
    [J]. BRITISH JOURNAL OF SURGERY, 2018, 105 (11) : 1417 - 1425
  • [5] Optimal Interval to Surgery After Neoadjuvant Chemoradiotherapy in Rectal Cancer: A Systematic Review and Meta-analysis[J] . Donglin Du,Zhourong Su,Dan Wang,Wenwen Liu,Zhengqiang Wei.Clinical Colorectal Cancer . 2018 (1)
  • [6] Optimal Timing to Surgery after Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer[J] . Zhifei Sun,Mohamed A. Adam,Jina Kim,Mithun Shenoi,John Migaly,Christopher R. Mantyh.Journal of the American College of Surgeons . 2015
  • [7] Pathological response, when increased by longer interval, is a marker but not the cause of good prognosis in rectal cancer : 17-year follow-up of the Lyon R90-01 randomized trial[J] . Eddy Cotte,Guillaume Passot,Evelyne Decullier,Christelle Maurice,Olivier Glehen,Yves Fran?ois,Fabrice Lorchel,Olivier Chapet,Jean-Pierre Gerard.International Journal of Radiation Oncology, Biol . 2015
  • [8] Timing of Surgery After Long-Course Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Systematic Review of the Literature[J] . Jake D. Foster,Emma L. Jones,Stephen Falk,Edwin J. Cooper,Nader K. Francis.Diseases of the Colon & Rectum . 2013 (7)
  • [9] Optimal Timing of Surgery After Chemoradiation for Advanced Rectal Cancer: Preliminary Results of a Multicenter, Nonrandomized Phase II Prospective Trial[J] . Julio Garcia-Aguilar,David D. Smith,Karin Avila,Emily K. Bergsland,Peiguo Chu,Richard M. Krieg.Annals of Surgery . 2011 (1)
  • [10] An Interval >7 Weeks between Neoadjuvant Therapy and Surgery Improves Pathologic Complete Response and Disease–Free Survival in Patients with Locally Advanced Rectal Cancer[J] . Hagit Tulchinsky,Einat Shmueli,Arie Figer,Joseph M. Klausner,Micha Rabau.Annals of Surgical Oncology . 2008 (10)